8 results
Cardiovascular and renal effects comparison between SGLT-2 inhibitors
 - Canagliflozin (Invokana)
 - Dapagliflozin (Farxiga)
 - Empagliflozin
comparison between SGLT ... (Invokana) - Dapagliflozin ... (Farxiga) - Empagliflozin ... cardiovascular #renal #SGLT2i ... #Inhibitors #pharmacology
Indications for and pharmacological properties of approved SGLT2 inhibitors

Canagliflozin - Dapagliflozin - Empagliflozin - Ertugliflozin

#SGLT2 #Inhibitors
properties of approved SGLT2 ... Canagliflozin - Dapagliflozin ... - Empagliflozin ... Ertugliflozin #SGLT2 ... #Inhibitors #pharmacology
Diabetes Combination Tablets - Estimated A1c Lowering 
Metformin + DPP4 
• Janumet (metformin + sitagliptin) 
•
Metformin + SGLT2 ... Synjardy (metformin + empagliflozin ... ) Dpp4 + SGLT2 ... (linagliptin + empagliflozin ... Tablets #Oral #DM2 #Pharmacology
Summary of Diuretic Agents 
Subclass, Drug, Mechanism of Action, Effects, Clinical Applications, Pharmacokinetics, Toxicities, Interaction
CARBONIC ANHYDRASE
Acetazolamide, others SGLT2 ... Canagliflozin • Dapagliflozin ... , empagliflozin ... #Medications #Pharmacology
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors ... - Pharmacology ... Action: Inhibits SGLT2 ... loss (~2-3kg) • Empagliflozin ... #Inhibitors #Pharmacology
SGLT2 inhibitors, also called gliflozins, are a class of medications that alter essential physiology of the
SGLT2 inhibitors ... nephron; unlike SGLT1 ... inhibitors that modulate ... (Farxiga®) and empagliflozin ... , #empagliflozin
Mechanism of Action for Common Diabetes Medications

 • SGLT2i (Dapagliflozin)
 • TZD (Pioglitazone)
 • Biguanides (Metformin)
Medications • SGLT2i ... (Dapagliflozin) ... #Medications #pharmacology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
when compared to SGLT2 ... empagliflozin and ... semaglutide #Diabetes #Pharmacology